<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=716879285080964&amp;ev=PageView&amp;noscript=1">

Nathan-Lighthizer-OD-picNate Lighthizer, OD, FAAO

Dr. Nathan Lighthizer is a graduate of Pacific University College of Optometry. Upon graduation, he completed a residency in Family Practice Optometry with an emphasis in Ocular Disease through Northeastern State University Oklahoma College of Optometry. Dr. Lighthizer has since joined the faculty at the Oklahoma College of Optometry and serves as an Associate Professor, Assistant Dean of Clinical Care Services, Director of Continuing Education and Chief of Specialty Care Clinics.

Dr. Lighthizer lectures nationally on numerous topics, most notably advanced ophthalmic procedures, electrodiagnostics, and ocular disease.

To have an EyePromise Representative reach out to you please complete the form below.

To have a Diopsys Representative reach out to you please call 973-244-0622 or email info@diopsys.com. 

This webinar video represents the experiences and opinions of Nate Lighthizer, OD, FAAO. Physicians should make medical decisions based on the individual facts and history of each patient. Originally presented on November 19, 2019.

 

DVS: Additional Supporting Science

The Diabetes Visual Function Supplement Study (DiVFuSS) was designed to test the effects of a novel, multi-component nutritional supplement (DVS) on visual function. Participants included patients with both type 1 and type 2 diabetes.

DiVFuSSstudy results showed significant improvements in visual function for patients with diabetes without effecting blood sugar levels

DiVFuSS Formula Results 

  • Significantly increased contrast sensitivity by 19%.
  • Color vision improvement of 21%.
  • Macular pigment increase of 31%.
  • Improved cholesterol (HDL and LDL) and inflammation
  • The supplement achieved the aforementioned results without significantly affecting blood sugar control (A1c).

 

Who Should Take DVS?

  • Adults with diabetes for more than 5 years.
  • Adults with diabetic retinopathy of any severity.
  • Adults with diabetes and reduced visual function or low MPOD.
  • Patients with sub-optimal blood glucose control.

 

Benefits to Your Practice

  • Improved patient care
  • Practice differentiation
  • Referrals from patients and prevention-oriented providers
  • Increased practice revenue

 

1. Wroblewski, John J., et al. Reproducibility of Fixed-Luminance and Multi-Luminance Flicker Electroretinography in Patients With Diabetic Retinopathy Using an Office-Based Testing Paradigm. Journal of Diabetes Science and Technology, Oct. 2019, doi:10.1177/1932296819882719. 2. Holm K, et al. Peripheral retinal function assessed with 30-Hz flicker seems to improve after treatment with Lucentis in patients with diabetic macular oedema. Doc Ophthalmol. 2015;131:43-51. 3. Pescosolido N, et al. Role of Electrophysiology in the Early Diagnosis and Follow-Up of Diabetic Retinopathy. J Diabetes Res. 2015;doi.org/10.1155/2015/319692. 4. Tzekov R, et al. The Electroretinogram in Diabetic Retinopathy Surv Ophthalmol. 1999;doi:10.1016/s0039-6257(99)00063-6. 5. Chous AP, et al. The Diabetes Visual Function Supplement Study (DiVFuSS). Br J Ophthalmol. 2016;doi:10.1136/bjophthalmol-2014-306534. 6. Kowluru RA, et al. Beneficial effects of the nutritional supplements on the development of diabetic retinopathy. Nutr Metab. 2014;doi:10.1186/1743-7075-11-8.